Antipsychotic Mortality Risk Analysis By Independent Group Needed
Executive Summary
Pharmaceutical manufacturers should allow an independent group to analyze their data on antipsychotic drugs to better understand characteristics associated with potential drug-related mortality, researchers suggest in the Oct. 19 Journal of the American Medical Association